[1]潘光栋,严律南,王新平,等.RNA干扰逆转肝细胞癌多药耐药[J].陆军军医大学学报(原第三军医大学学报),2008,30(01):35-38.
　PAN Guang-dong,YAN Lu-nan,WANG Xin-ping,et al.Reversal of multidrug resistance of hepatocellular carcinoma by siRNA/mdr1[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(01):35-38.
点击复制

RNA干扰逆转肝细胞癌多药耐药(/HTML )
分享到：

陆军军医大学学报（原第三军医大学学报）[ISSN:1000-5404/CN:51-1095/R]

卷:
30卷
期数:
2008年第01期
页码:
35-38
栏目:
论著
出版日期:
2008-01-15

文章信息/Info

Title:
Reversal of multidrug resistance of hepatocellular carcinoma by siRNA/mdr1
作者:
潘光栋; 严律南; 王新平; 杨家印; 夏庆杰; 闫乃红; 陈清英; 张发强
广西医科大学第五附属医院肝胆外科；四川大学华西医院普通外科
Author(s):
PAN Guang-dong;  YAN Lu-nan;  WANG Xin-ping;  YANG Jia-yin;  XIA Qing-jie;  YAN Nai-hong;  CHEN Qing-ying;  ZHANG Fa-qiang
Department of Hepatobiliary Surgery, the Fifth Affiliated Hospital, Guangxi Medical University；Department of General Surgery, West China Hospital, Sichuan University
关键词:
肝细胞癌; 多药耐药; RNA干扰
Keywords:
hepatocellular carcinoma;  multidrug resistance;  RNA interference
分类号:
R394-33; R73-36; R735.7
文献标志码:
A
摘要:
目的  筛选高效dsRNA/mdr1，以备研究RNA干扰逆转肝细胞癌多药耐药之用。  方法  首先根据siRNA设计原则，以多药耐药基因（mdr1）为靶基因，设计并选择4～5条siRNA/mdr1，经BLAST后体外转录法合成dsRNA/mdr1，用Oligofectamine试剂分别转染HepG2/mdr1，然后从mRNA、蛋白（P-gp）表达水平和细胞功能变化评价HepG2/mdr1耐药性被逆转的程度，比较各个dsRNA/mdr1的逆转效率，筛选出有效的siRNA/mdr1。  结果  成功合成5条dsRNA/mdr1(其中1条为阴性对照)，dsRNA/mdr1-4 mRNA表达（18.73±1.33）％、蛋白表达变化(79.1±1.6)%~（16.8±0.4)%与其他各组细胞比较，有显著性差异；细胞内柔红霉素(DNR)累积量也较其他组明显增加（平均荧光强度79.58，阳性率84.25%，P<0.05）。  结论  体外转录法结合脂质体转染适用于筛选高效siRNA，肯定了siRNA干扰序列能够有效阻抑mdr1基因编码蛋白p170的功能。
Abstract:
Objective  To screen effective dsRNA/mdr1 for studying the reversal of multidrug resistance of hepatocellular carcinoma (HCC) by RNA interference (RNAi).   Methods  dsRNA/mdr1 targeting multidrug resistance gene (mdr1) was designed and synthesized by in vitro transcription. HepG2/mdr1 in 6 groups was transfected with the complex of different dsRNA/mdr1 (dsRNA/mdr1-1, dsRNA/mdr1-2, dsRNA/mdr1-3, dsRNA/mdr1-4, dsRNA/mdr1-5) using Oligofectamine. Then the cells were collected to measure the expression of mRNA/mdr1, P-glycoprotein and the accumulation of DNR.   Results  Five dsRNA/mdr1 were successfully synthesized including one negative. The expression of mRNA/mdr1 [(18.73±1.33)％] and P-glycoprotein [from (79.1±1.6)% before transfection down to (16.8±0.4)%] in dsRNA/mdr1-4 was significantly lower than that of other groups (P<0.05). Accumulation of DNR in dsRNA/mdr1-4 was higher than that in other groups (P<0.05).   Conclusion   In vitro transcription combined with liposome is fit to screen the effective dsRNA/mdr1. siRNA/mdr1 could suppress the expression of P-glycoprotein coded by mdr1 gene.

相似文献/References:

[1]宋春丽,任吉华,张祯祯,等.SIRT1基因沉默诱导肝癌细胞老化及其机制[J].陆军军医大学学报(原第三军医大学学报),2012,34(19):1929.
　Song Chunli,Ren Jihua,Zhang Zhenzhen,et al.Silent information regulator 1 gene induces aging of hepatocellular carcinoma cells via p53/p21 pathway[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(01):1929.
[2]李建国,江小杰.原发性肝癌RUNX3基因启动子区甲基化及其意义[J].陆军军医大学学报(原第三军医大学学报),2012,34(19):1933.
　Li Jianguo,Jiang Xiaojie.Methylation of RUNX3 gene promoter in HCC and its significance[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(01):1933.
[3]左国华,梁平,李洪艳.肝细胞癌免疫磁珠的制备及鉴定[J].陆军军医大学学报(原第三军医大学学报),2005,27(16):1700.
[4]张小丽,高建,贾茜,等.肝癌干细胞样细胞的分离及其耐药性受PI3K/Akt通路调节[J].陆军军医大学学报(原第三军医大学学报),2013,35(02):99.
　Zhang Xiaoli,Gao Jian,Jia Qian,et al.Isolation of HCC cancer stem-like cells and chemo-resistance mediated by PI3K/Akt pathway[J].J Amry Med Univ (J Third Mil Med Univ),2013,35(01):99.
[5]于月新,李巨.紫草素逆转绒癌细胞JAR/MTX耐药与survivin和Bcl-2表达关系研究[J].陆军军医大学学报(原第三军医大学学报),2007,29(19):1880.
　YU Yue-xin,LI Ju.Relationship between the reverse effect of shikonin on methotrexate-resistant human choriocarcinoma cell line JAR/MTX and expressions of survivin and Bcl-2[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(01):1880.
[6]杨兆瑞,吴晴,陈嘉薇,等.HIF-1α、JNK1、P-gp、MRP1和LRP蛋白在胃癌中的表达与临床病理及预后的关系[J].陆军军医大学学报(原第三军医大学学报),2007,29(18):1755.
　YANG Zhao-rui,WU Qing,CHEN Jia-wei,et al.Expressions, clinicopathological features and prognostic significance of HIF-1α, JNK1, P-gp, MRP1 and LRP proteins in human gastric carcinoma[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(01):1755.
[7]谢斌,唐春,吴刚,等.c-Met、MMP-2、MMP-9在肝细胞癌中的表达及临床意义[J].陆军军医大学学报(原第三军医大学学报),2008,30(12):1140.
　XIE Bin,TANG Chun,WU Gang,et al.Expressions and clinical significances of c-Met, MMP-2, MMP-9 in metastasis of human hepatocellular carcinoma: report of 47 cases[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(01):1140.
[8]廖翠薇,邹利光,卫静,等.实验性肝细胞癌SPIO增强MRI及其病理学对照研究[J].陆军军医大学学报(原第三军医大学学报),2006,28(01):38.
[9]李静,沈宜,杨麟,等.小鼠肝癌细胞(H22)源外泌体的体内抗肝癌作用研究[J].陆军军医大学学报(原第三军医大学学报),2008,30(19):1836.
　LI Jing,SHEN Yi,YANG Lin,et al.Antitumor effects of exosomes derived from a mouse hepatoma carcinoma cell line H22[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(01):1836.
[10]李昆霖,吴国明,戢福云,等.人小细胞肺癌多药耐药细胞差异表达基因的克隆研究[J].陆军军医大学学报(原第三军医大学学报),2006,28(24):2403.

更新日期/Last Update: 2008-05-05